Status:
ENROLLING_BY_INVITATION
The Effects of Kefir on Pediatric Obesity
Lead Sponsor:
China Medical University Hospital
Conditions:
Obesity
Eligibility:
All Genders
7-17 years
Phase:
NA
Brief Summary
Kefir, a traditional fermented dairy product in the North Caucasus region, is produced through the fermentation of milk by lactic acid bacteria and yeast. In murine studies, it has been observed that ...
Eligibility Criteria
Inclusion
- body weight above 40 kilograms, body mass index (BMI)-for-age above the 95th percentile
Exclusion
- diabetes mellitus, liver diseases other than non-alcoholic fatty liver disease, cardiovascular diseases other than hypertension and dyslipidemia, renal diseases, neurologic diseases, growth hormone deficiency, thyroid diseases, adrenal disorders, any use of medication for more than 6 months before or during this study, and any adverse responses to dairy products.
Key Trial Info
Start Date :
July 6 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06500104
Start Date
July 6 2024
End Date
December 31 2025
Last Update
December 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
China Medical University Children's Hospital
Taichung, Taiwan, 404